A new study published on the preprint server medRxiv* finds improved Fc cross-reactivity against certain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOCs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback